Moderna, Inc.MRNANASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank56
3Y CAGR-45.7%
5Y CAGR+85.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-45.7%/yr
vs +284.2%/yr prior
5Y CAGR
+85.8%/yr
Recent deceleration
Acceleration
-329.9pp
Decelerating
Percentile
P56
Within normal range
vs 5Y Ago
22.2x
Strong expansion
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $868.00M | -40.7% |
| 2024 | $1.46B | -68.8% |
| 2023 | $4.69B | -13.3% |
| 2022 | $5.42B | +107.0% |
| 2021 | $2.62B | +6578.7% |
| 2020 | $39.18M | +26.3% |
| 2019 | $31.02M | +24.8% |
| 2018 | $24.86M | +21.1% |
| 2017 | $20.54M | +35.9% |
| 2016 | $15.11M | - |